Bio Techne Stock Quote TECH - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

80.60

Bid

79.26

Ask

81.00

Volume

969,063

78.77 Day's Range 81.32

51.79 52 Week Range 85.95

Market Cap

12.701B

Previous Close

78.67

Open

79.72

Last Trade

14079

80.6

(formt)

Last Trade Time

Financial Volume

$ 77,836,652

VWAP

80.3216

Average Volume (3m)

936,664

Shares Outstanding

157,584,637

Dividend Yield

0.40%

PE Ratio

44.55

Earnings Per Share (EPS)

1.81

Revenue

1.14B

Net Profit

285.26M

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.bio-techne.com

Headquarters

Minneapolis, Minnesota, USA

Founded

1970

Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TECH. The last closing price for Bio Techne was $78.67. Over the last year, Bio Techne shares have traded in a share price range of $ 51.79 to $ 85.95.

Bio Techne currently has 157,584,637 shares outstanding. The market capitalization of Bio Techne is $12.40 billion. Bio Techne has a price to earnings ratio (PE ratio) of 44.55.

Overall Flow

Bullish

Net Premium

190k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Form 4 - Statement of changes in beneficial ownership of securities

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS PR Newswire MINNEAPOLIS, July 15, 2024 MINNEAPOLIS, July 15, 2024 /PRNewswire/...

Form 4 - Statement of changes in beneficial ownership of securities

Form SD - Specialized disclosure report

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES PR Newswire MINNEAPOLIS, May 31, 2024 MINNEAPOLIS, May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that...

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE PR Newswire MINNEAPOLIS, May 30, 2024 MINNEAPOLIS, May 30, 2024 /PRNewswire/ -- Bio-Techne...

ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing

ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing PR Newswire ST. PAUL, Minn., May 29, 2024 ST. PAUL, Minn...

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE PR Newswire MINNEAPOLIS, May 23, 2024 MINNEAPOLIS, May 23, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY PR Newswire MINNEAPOLIS, May 22, 2024 MINNEAPOLIS...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	4.67	6.15040168576	75.93	81.32	74.2	775736	77.30743457	CS
4	8.82	12.2875452772	71.78	81.32	70.3	842569	75.14309298	CS
12	3.71	4.82507478216	76.89	85.57	70.3	936664	77.29400551	CS
26	8	11.0192837466	72.6	85.57	61.16	1054368	72.82994319	CS
52	-4.57	-5.36573911002	85.17	85.95	51.79	1038371	71.01093705	CS
156	-37.765	-31.9055464031	118.365	135.9625	51.79	678770	79.19265856	CS
260	28.05	53.37773549	52.55	135.9625	38.7925	483811	77.99157997	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.45M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M